Vertex Pharmaceuticals Inc VRTX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/26/21 EST
212.61quote price arrow up+0.06 (+0.03%)
Volume
357,920
Close
212.55quote price arrow down-0.43 (-0.20%)
Volume
2,722,371
52 week range
197.47 - 306.08

...

Loading . . .

KEY STATS

  • Open214.67
  • Day High215.50
  • Day Low209.34
  • Prev Close212.98
  • 52 Week High306.08
  • 52 Week High Date07/07/20
  • 52 Week Low197.47
  • 52 Week Low Date03/18/20
  • Market Cap55.255B
  • Shares Out259.96M
  • 10 Day Average Volume2.25M
  • Dividend-
  • Dividend Yield-
  • Beta0.62
  • 1 Year % Change-4.81

RATIOS/PROFITABILITY

  • EPS (TTM)10.30
  • P/E (TTM)20.63
  • Fwd P/E (NTM)19.52
  • EBITDA (MRQ)2.979B
  • ROE (MRQ)36.71%
  • Revenue (MRQ)6.206B
  • Gross Margin (MRQ)88.14%
  • Net Margin (MRQ)43.70%
  • Debt To Equity (MRQ)6.69%

EVENTS

  • Earnings Date04/27/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

QUOTE FINDER

Profile

MORE
Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. The Company's marketed medicines are ORKAMBI and KALYDECO. ORKAMBI (lumacaftor in combination with ivacaftor) is approved as a treatment for patients having...
Jeffrey Leiden M.D. Ph.D.
Chairman
Reshma Kewalramani M.D.
President
Charles Wagner Jr.
Chief Financial Officer
Michael Parini J.D.
Executive Vice President
Carmen Bozic
Executive Vice President
Address
50 Northern Ave
Boston, MA
02210-1862
United States